HLN vs. GEHC, CNC, HUM, IQV, TAK, BIIB, IDXX, ALC, RMD, and COR
Should you be buying Haleon stock or one of its competitors? The main competitors of Haleon include GE HealthCare Technologies (GEHC), Centene (CNC), Humana (HUM), IQVIA (IQV), Takeda Pharmaceutical (TAK), Biogen (BIIB), IDEXX Laboratories (IDXX), Alcon (ALC), ResMed (RMD), and Cencora (COR). These companies are all part of the "medical" sector.
Haleon (NYSE:HLN) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership, risk and community ranking.
Haleon pays an annual dividend of $0.21 per share and has a dividend yield of 2.5%. GE HealthCare Technologies pays an annual dividend of $0.12 per share and has a dividend yield of 0.1%. Haleon pays out 70.0% of its earnings in the form of a dividend. GE HealthCare Technologies pays out 3.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
Haleon has a net margin of 9.68% compared to GE HealthCare Technologies' net margin of 8.05%. GE HealthCare Technologies' return on equity of 25.32% beat Haleon's return on equity.
6.7% of Haleon shares are owned by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are owned by institutional investors. 0.3% of GE HealthCare Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
GE HealthCare Technologies received 4 more outperform votes than Haleon when rated by MarketBeat users. Likewise, 53.57% of users gave GE HealthCare Technologies an outperform vote while only 39.29% of users gave Haleon an outperform vote.
GE HealthCare Technologies has higher revenue and earnings than Haleon. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Haleon, indicating that it is currently the more affordable of the two stocks.
In the previous week, GE HealthCare Technologies had 7 more articles in the media than Haleon. MarketBeat recorded 11 mentions for GE HealthCare Technologies and 4 mentions for Haleon. GE HealthCare Technologies' average media sentiment score of 0.60 beat Haleon's score of 0.20 indicating that GE HealthCare Technologies is being referred to more favorably in the news media.
GE HealthCare Technologies has a consensus target price of $94.80, indicating a potential upside of 15.81%. Given GE HealthCare Technologies' higher possible upside, analysts plainly believe GE HealthCare Technologies is more favorable than Haleon.
Haleon has a beta of 0.28, suggesting that its share price is 72% less volatile than the S&P 500. Comparatively, GE HealthCare Technologies has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500.
Summary
GE HealthCare Technologies beats Haleon on 14 of the 19 factors compared between the two stocks.
Get Haleon News Delivered to You Automatically
Sign up to receive the latest news and ratings for HLN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HLN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
